微侵袭性口腔状细胞癌:一个管理协议
Uma Shanker Pal1, Seema Devi2, Meleti Venkata Sowmya1
1Department of Oral and Maxillofacial Surgery, King George's Medical University, Lucknow, Uttar Pradesh, India.
National journal of maxillofacial surgery
|January 20, 2025
概括
微创性口腔状细胞癌 (MISCC) 的管理需要仔细考虑诊断错误和预后结果. 早期发现和精确管理潜在恶性疾病对于预防癌症转变至关重要.
科学领域:
- 在瘤学瘤学.
- 口腔病理学 口腔病理学
背景情况:
- 微侵袭性口腔状细胞癌 (MISCC) 是一种早期的口腔癌,其特征是地下膜破裂和侵袭深度高达2mm.
- 口腔潜在恶性疾病 (OPMDs) 是口腔癌的前体,需要谨慎监测.
研究的目的:
- 为MISCC制定一个管理协议.
- 评估OPMD和MISCC之间的关联.
主要方法:
- 进行了全面的电子和手动文献搜索.
- 根据包含/排除标准,选择和评估了14篇相关文章.
- 来自选定的文章的数据进行了表格化分析.
主要成果:
- 在14篇审查的文章中,在12篇中观察到OPMD和MISCC之间的关联.
- 尽管有NCCN的指导方针,但14例MISCC病例中有3例显示淋巴结转移.
- 复发和第二次原发性瘤是MISCC管理中的重大问题.
结论:
- 开发了MISCC的管理协议,整合了他的病理学,临床和放射学发现.
- 建议对OPMD进行严格的3年随访,以防止恶性转变.
- 建议对MISCC患者进行4-8年的随访.
相关概念视频
Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.


